A case study on decentralized manufacturing of 3D printed medicines

• Published in: International journal of pharmaceutics: X Vol. 5; p. 100184
• Main Authors: Seoane-Viaño, Iria, Xu, Xiaoyan, Ong, Jun Jie, Teyeb, Ahmed, Gaisford, Simon, Campos-Álvarez, André, Stulz, Anja, Marcuta, Carmen, Kraschew, Lilia, Mohr, Wolfgang, Basit, Abdul W., Goyanes, Alvaro
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.12.2023; Elsevier
• Subjects: Additive manufacturing of drug products and drug delivery systems; Decentralised and distributed fabrication of formulations; Digital healthcare and industry 4.0; Direct powder extrusion of personalized pharmaceuticals; Process analytical technologies; Real-time release testing; Research Paper; Three-dimensional printing using M3DIMAKER; Process analytical technologies; Decentralised and distributed fabrication of formulations; Direct powder extrusion of personalized pharmaceuticals; Additive manufacturing of drug products and drug delivery systems; Real-time release testing; Digital healthcare and industry 4.0; Three-dimensional printing using M3DIMAKER

Pharmaceutical 3D printing (3DP) is one of the emerging enabling technologies of personalised medicines as it affords the ability to fabricate highly versatile dosage forms. In the past 2 years, national medicines regulatory authorities have held consultations with external stakeholders to adapt reg...